Skip to Main Content

Paper Details

n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.
Diabetes Care
40
2021
ALA, DHA, DPA, EPA, Fatty Acid, Participant, T2D, Type 2 Diabetes, diabetes, docosahexaenoic acid, docosapentaenoic acid, eicosapentaenoic acid, fatty acid, fatty acids, of -linolenic acid, participant, participants, type 2 diabetes
Author NameAffiliation
Nathan TintleDordt University
Nathan TintleFatty Acid Research Institute
Weihua GuanUniversity of Minnesota
Nita G ForouhiUniversity of Cambridge School of Clinical Medicine
Nicholas J WarehamUniversity of Cambridge School of Clinical Medicine
Lars LindClinical Nutrition and Metabolism, Uppsala University
Lars LindUppsala University
Aladdin H ShadyabUniversity of California San Diego School of Medicine
Jennifer G RobinsonUniversity of Iowa
Graham G GilesSchool of Public Health, University of Minnesota
Graham G GilesThe University of Melbourne
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Matti UusitupaFatty Acid Research Institute
Jaakko TuomilehtoFinnish Institute for Health and Welfare
Jaakko TuomilehtoKing Abdulaziz University
Jaana LindströmFinnish Institute for Health and Welfare
Markku LaaksoUniversity of Eastern Finland
David S SiscovickThe New York Academy of Medicine
  • 1 - 18

Datasets

Release 1.2